Duloxetine + Pregabalin + Placebo
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Diabetic Peripheral Neuropathic Pain
Conditions
Diabetic Peripheral Neuropathic Pain
Trial Timeline
Apr 1, 2015 → May 13, 2017
NCT ID
NCT02417935About Duloxetine + Pregabalin + Placebo
Duloxetine + Pregabalin + Placebo is a approved stage product being developed by Shionogi for Diabetic Peripheral Neuropathic Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT02417935. Target conditions include Diabetic Peripheral Neuropathic Pain.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02417935 | Approved | Completed |
Competing Products
20 competing products in Diabetic Peripheral Neuropathic Pain